Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 5,500 shares at $349.00 ($1.6M) on 2019-11-12, disclosed to the SEC on 2019-11-13.
Open-market sale of $1.6M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,000 | $0 | 0.0% |
| 2 | $349.00 | 4,500 | $1.6M | 100.0% |
| Total | $285.55 avg | 5,500 | $1.6M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |